Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting

Background The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Prostate 2016-02, Vol.76 (2), p.125-139
Hauptverfasser: Miyahira, Andrea K., Lang, Joshua M., Den, Robert B., Garraway, Isla P., Lotan, Tamara L., Ross, Ashley E., Stoyanova, Tanya, Cho, Steve Y., Simons, Jonathan W., Pienta, Kenneth J., Soule, Howard R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 139
container_issue 2
container_start_page 125
container_title The Prostate
container_volume 76
creator Miyahira, Andrea K.
Lang, Joshua M.
Den, Robert B.
Garraway, Isla P.
Lotan, Tamara L.
Ross, Ashley E.
Stoyanova, Tanya
Cho, Steve Y.
Simons, Jonathan W.
Pienta, Kenneth J.
Soule, Howard R.
description Background The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action‐tank‐structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure. Results The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high‐risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi‐modal care of high risk and oligometastatic patients. Discussion This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high‐risk and oligometastatic prostate cancer patients. Prostate 76:125–139, 2016. © 2015 Wiley Periodicals, Inc.
doi_str_mv 10.1002/pros.23107
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5830186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3923841411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5217-c44f4666803e02800ce860310b02754d5201ef0ebde3187fe17b9309b5f6bd303</originalsourceid><addsrcrecordid>eNpVUc1u1DAQthCILi0XHgBZ4krKOI7jhANStUCL1NJVAYF6sZxk0nVJ7OB4C3mJPnO9u-2qnGak-X5mviHkFYNDBpC-G7wbD1POQD4hMwalTAAy8ZTMIJWQZIzLPfJiHK8BIhzS52QvzTMpcyhn5PZs1QXTmLE2Q2es9hM1NqC_QRuMs9S1FLXvpre0w7DUHe0x6DHoYGq69o0d0lrbGv17eoGD84G23vU0LJGmwASdu7bFKTlxXYOWLh448w2HHtW6wX6iZ4jB2KsD8qzV3Ygv7-s--fH50_f5SXJ6fvxlfnSa1CJlMqmzrM3yPC-AI6QFQI1FDjGBKp4sskZEZ2wBqwY5K2SLTFYlh7ISbV41HPg--bDVHVZVj00dr_W6U4M3fYxAOW3U_xNrlurK3ShRcGBFHgXe3At492eFY1DXbuVt3FkxKaQoS1aubV4_ttnpP-QfAWwL-Gs6nHZzBmr9WbVOWG0-qxYX5982XeQkW44ZA_7bcbT_rXLJpVA_vx6rX5cfhbzkC1XwOxgJp6o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1757599190</pqid></control><display><type>article</type><title>Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Miyahira, Andrea K. ; Lang, Joshua M. ; Den, Robert B. ; Garraway, Isla P. ; Lotan, Tamara L. ; Ross, Ashley E. ; Stoyanova, Tanya ; Cho, Steve Y. ; Simons, Jonathan W. ; Pienta, Kenneth J. ; Soule, Howard R.</creator><creatorcontrib>Miyahira, Andrea K. ; Lang, Joshua M. ; Den, Robert B. ; Garraway, Isla P. ; Lotan, Tamara L. ; Ross, Ashley E. ; Stoyanova, Tanya ; Cho, Steve Y. ; Simons, Jonathan W. ; Pienta, Kenneth J. ; Soule, Howard R.</creatorcontrib><description>Background The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action‐tank‐structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure. Results The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high‐risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi‐modal care of high risk and oligometastatic patients. Discussion This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high‐risk and oligometastatic prostate cancer patients. Prostate 76:125–139, 2016. © 2015 Wiley Periodicals, Inc.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.23107</identifier><identifier>PMID: 26477609</identifier><identifier>CODEN: PRSTDS</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Academies and Institutes - trends ; biomarkers ; California ; Congresses as Topic - trends ; diagnosis ; Early Medical Intervention - methods ; Early Medical Intervention - trends ; Humans ; Interprofessional Relations ; Male ; molecular imaging ; oligometastatic ; Patient Care Team - trends ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - therapy ; Research Report ; therapeutics</subject><ispartof>The Prostate, 2016-02, Vol.76 (2), p.125-139</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><rights>2016 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5217-c44f4666803e02800ce860310b02754d5201ef0ebde3187fe17b9309b5f6bd303</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpros.23107$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpros.23107$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26477609$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miyahira, Andrea K.</creatorcontrib><creatorcontrib>Lang, Joshua M.</creatorcontrib><creatorcontrib>Den, Robert B.</creatorcontrib><creatorcontrib>Garraway, Isla P.</creatorcontrib><creatorcontrib>Lotan, Tamara L.</creatorcontrib><creatorcontrib>Ross, Ashley E.</creatorcontrib><creatorcontrib>Stoyanova, Tanya</creatorcontrib><creatorcontrib>Cho, Steve Y.</creatorcontrib><creatorcontrib>Simons, Jonathan W.</creatorcontrib><creatorcontrib>Pienta, Kenneth J.</creatorcontrib><creatorcontrib>Soule, Howard R.</creatorcontrib><title>Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>Background The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action‐tank‐structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure. Results The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high‐risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi‐modal care of high risk and oligometastatic patients. Discussion This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high‐risk and oligometastatic prostate cancer patients. Prostate 76:125–139, 2016. © 2015 Wiley Periodicals, Inc.</description><subject>Academies and Institutes - trends</subject><subject>biomarkers</subject><subject>California</subject><subject>Congresses as Topic - trends</subject><subject>diagnosis</subject><subject>Early Medical Intervention - methods</subject><subject>Early Medical Intervention - trends</subject><subject>Humans</subject><subject>Interprofessional Relations</subject><subject>Male</subject><subject>molecular imaging</subject><subject>oligometastatic</subject><subject>Patient Care Team - trends</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Research Report</subject><subject>therapeutics</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUc1u1DAQthCILi0XHgBZ4krKOI7jhANStUCL1NJVAYF6sZxk0nVJ7OB4C3mJPnO9u-2qnGak-X5mviHkFYNDBpC-G7wbD1POQD4hMwalTAAy8ZTMIJWQZIzLPfJiHK8BIhzS52QvzTMpcyhn5PZs1QXTmLE2Q2es9hM1NqC_QRuMs9S1FLXvpre0w7DUHe0x6DHoYGq69o0d0lrbGv17eoGD84G23vU0LJGmwASdu7bFKTlxXYOWLh448w2HHtW6wX6iZ4jB2KsD8qzV3Ygv7-s--fH50_f5SXJ6fvxlfnSa1CJlMqmzrM3yPC-AI6QFQI1FDjGBKp4sskZEZ2wBqwY5K2SLTFYlh7ISbV41HPg--bDVHVZVj00dr_W6U4M3fYxAOW3U_xNrlurK3ShRcGBFHgXe3At492eFY1DXbuVt3FkxKaQoS1aubV4_ttnpP-QfAWwL-Gs6nHZzBmr9WbVOWG0-qxYX5982XeQkW44ZA_7bcbT_rXLJpVA_vx6rX5cfhbzkC1XwOxgJp6o</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Miyahira, Andrea K.</creator><creator>Lang, Joshua M.</creator><creator>Den, Robert B.</creator><creator>Garraway, Isla P.</creator><creator>Lotan, Tamara L.</creator><creator>Ross, Ashley E.</creator><creator>Stoyanova, Tanya</creator><creator>Cho, Steve Y.</creator><creator>Simons, Jonathan W.</creator><creator>Pienta, Kenneth J.</creator><creator>Soule, Howard R.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20160201</creationdate><title>Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting</title><author>Miyahira, Andrea K. ; Lang, Joshua M. ; Den, Robert B. ; Garraway, Isla P. ; Lotan, Tamara L. ; Ross, Ashley E. ; Stoyanova, Tanya ; Cho, Steve Y. ; Simons, Jonathan W. ; Pienta, Kenneth J. ; Soule, Howard R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5217-c44f4666803e02800ce860310b02754d5201ef0ebde3187fe17b9309b5f6bd303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Academies and Institutes - trends</topic><topic>biomarkers</topic><topic>California</topic><topic>Congresses as Topic - trends</topic><topic>diagnosis</topic><topic>Early Medical Intervention - methods</topic><topic>Early Medical Intervention - trends</topic><topic>Humans</topic><topic>Interprofessional Relations</topic><topic>Male</topic><topic>molecular imaging</topic><topic>oligometastatic</topic><topic>Patient Care Team - trends</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Research Report</topic><topic>therapeutics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miyahira, Andrea K.</creatorcontrib><creatorcontrib>Lang, Joshua M.</creatorcontrib><creatorcontrib>Den, Robert B.</creatorcontrib><creatorcontrib>Garraway, Isla P.</creatorcontrib><creatorcontrib>Lotan, Tamara L.</creatorcontrib><creatorcontrib>Ross, Ashley E.</creatorcontrib><creatorcontrib>Stoyanova, Tanya</creatorcontrib><creatorcontrib>Cho, Steve Y.</creatorcontrib><creatorcontrib>Simons, Jonathan W.</creatorcontrib><creatorcontrib>Pienta, Kenneth J.</creatorcontrib><creatorcontrib>Soule, Howard R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miyahira, Andrea K.</au><au>Lang, Joshua M.</au><au>Den, Robert B.</au><au>Garraway, Isla P.</au><au>Lotan, Tamara L.</au><au>Ross, Ashley E.</au><au>Stoyanova, Tanya</au><au>Cho, Steve Y.</au><au>Simons, Jonathan W.</au><au>Pienta, Kenneth J.</au><au>Soule, Howard R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>76</volume><issue>2</issue><spage>125</spage><epage>139</epage><pages>125-139</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><coden>PRSTDS</coden><abstract>Background The 2015 Coffey‐Holden Prostate Cancer Academy Meeting, themed: “Multidisciplinary Intervention of Early, Lethal Metastatic Prostate Cancer,” was held in La Jolla, California from June 25 to 28, 2015. Methods The Prostate Cancer Foundation (PCF) sponsors an annual, invitation‐only, action‐tank‐structured meeting on a critical topic concerning lethal prostate cancer. The 2015 meeting was attended by 71 basic, translational, and clinical investigators who discussed the current state of the field, major unmet needs, and ideas for addressing earlier diagnosis and treatment of men with lethal prostate cancer for the purpose of extending lives and making progress toward a cure. Results The questions addressed at the meeting included: cellular and molecular mechanisms of tumorigenesis, evaluating, and targeting the microenvironment in the primary tumor, advancing biomarkers for clinical integration, new molecular imaging technologies, clinical trials, and clinical trial design in localized high‐risk and oligometastatic settings, targeting the primary tumor in advanced disease, and instituting multi‐modal care of high risk and oligometastatic patients. Discussion This article highlights the current status, greatest unmet needs, and anticipated field changes that were discussed at the meeting toward the goal of optimizing earlier interventions to potentiate cures in high‐risk and oligometastatic prostate cancer patients. Prostate 76:125–139, 2016. © 2015 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>26477609</pmid><doi>10.1002/pros.23107</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-4137
ispartof The Prostate, 2016-02, Vol.76 (2), p.125-139
issn 0270-4137
1097-0045
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5830186
source Wiley-Blackwell Journals; MEDLINE
subjects Academies and Institutes - trends
biomarkers
California
Congresses as Topic - trends
diagnosis
Early Medical Intervention - methods
Early Medical Intervention - trends
Humans
Interprofessional Relations
Male
molecular imaging
oligometastatic
Patient Care Team - trends
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - therapy
Research Report
therapeutics
title Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A07%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multidisciplinary%20intervention%20of%20early,%20lethal%20metastatic%20prostate%20cancer:%20Report%20from%20the%202015%20Coffey-Holden%20Prostate%20Cancer%20Academy%20Meeting&rft.jtitle=The%20Prostate&rft.au=Miyahira,%20Andrea%20K.&rft.date=2016-02-01&rft.volume=76&rft.issue=2&rft.spage=125&rft.epage=139&rft.pages=125-139&rft.issn=0270-4137&rft.eissn=1097-0045&rft.coden=PRSTDS&rft_id=info:doi/10.1002/pros.23107&rft_dat=%3Cproquest_pubme%3E3923841411%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1757599190&rft_id=info:pmid/26477609&rfr_iscdi=true